Pfizer Cibinqo — Revenues: decreased by 2.6% to $76.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.0%, from $58.00M to $76.00M.
pfe_segment_cibinqo_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $5.00M | $1.00M | $11.00M | $10.00M | $16.00M | $38.00M | $37.00M | $37.00M | $42.00M | $47.00M | $63.00M | $63.00M | $58.00M | $69.00M | $79.00M | $78.00M | $76.00M |
| QoQ Change | — | — | — | — | -80.0% | >999% | -9.1% | +60.0% | +137.5% | -2.6% | +0.0% | +13.5% | +11.9% | +34.0% | +0.0% | -7.9% | +19.0% | +14.5% | -1.3% | -2.6% |
| YoY Change | — | — | — | — | — | — | — | +220.0% | >999% | +236.4% | +270.0% | +162.5% | +23.7% | +70.3% | +70.3% | +38.1% | +46.8% | +25.4% | +23.8% | +31.0% |